Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
Work
Year: 2002
Type: article
Abstract: Constitutive activation of KIT receptor tyrosine kinase is critical in the pathogenesis of gastrointestinal stromal tumors. Imatinib mesylate, a selective tyrosine kinase inhibitor, has been shown in ... more
Source: New England Journal of Medicine
Authors George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg +16 more
Institutions Dana-Farber Cancer Institute, Fox Chase Cancer Center, Portland VA Medical Center, Oregon Health & Science University, University of Turku +2 more
Cites: 21
Cited by: 4,280
Related to: 10
FWCI: 126.5
Citation percentile (by year/subfield): 99.94
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze